2014-02-24 03:17:01 - Proteomics: Technologies and Global Markets - a new market research report on companiesandmarkets.com
The research segment of the global proteomics market is suggested to have reached a value of around $1.8 billion at the end of 2012, and is forecast to hit a total of $2.9 billion by 2017. This suggests a CAGR of 9.7% between 2012 and 2017 and accounts for 32.5% of the total value of the global proteomics market. The research market has been the main focus of proteomics products, which has resulted in strong growth. The market has been shifting toward applied end markets, including drug discovery and development, diagnostics, and applied laboratories. This trend is expected to continue as the industry moves toward more applied applications of proteomics. Research institutions, however, are expected to remain the focus of
innovative technologies in the two key proteomics technologies: mass spectrometry and biochips.The diagnostics market is the highest growth end-user market for proteomics. It reached $246.1 million in 2012; it is continuing to grow at a strong CAGR of 43.5% and is expected to reach a value of nearly $1.5 billion in 2017. Key growth drivers for the diagnostics market include a modest but growing pipeline of proteomics-based tests; increasing acceptance of multiplexed diagnostics tests; a high discovery rate of protein biomarkers; and a strong need for automated, rapid, and less-costly tests.The proteomics industry is extremely diverse, with intense competition in many market segments. The industry contains a range of lifecycle technologies, which makes it attractive to companies that can innovate in early or emerging market segments. Proteomics technologies have proven to be indispensable tools within the life-science industries, and they will continue to provide opportunities for innovators in the future.Exciting developments likely to affect the future of proteomics include platforms with both genomic and proteomic content, the use of next-generation sequencing platforms for proteomics analysis, the development of novel protein and peptide affinity chemistries, and label-free methods.The two key proteomic technologies - mass spectrometry and biochips - are benefiting from an explosion of new proteomics content from the large-scale genomic and proteomic initiatives. This proteomic content is driving the discovery of new biomarkers that are important in disease processes.At the same time, improvements in technologies are driving proteomic applications. Increasing miniaturization and integration of biochip devices, as well as improvement in mass spectrometry workflow and instruments, are creating new applications in drug discovery and development and diagnostics.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.